Font Size: a A A
Keyword [paclitaxel resistance]
Result: 41 - 60 | Page: 3 of 5
41. CAFs Enhance Paclitaxel Resistance By Inducing EMT Through IL-6/JAK2/STAT3 Pathway
42. A Study On The Mechanism Of PGAM1 Induced Paclitaxel Resistance Via Modulating Glycolysis Flux In Ovarian Cancer Cells
43. Effect Of MiR-223-5p On Paclitaxel Resistance Of Hepatocellular Carcinoma Cell Line BEL-7402
44. Effect Of S100A14-siRNA On Apoptosis And Drug Resistance In Breast Cancer Paclitaxel-resistant Cell Line MCF-7 TaxR
45. Study On The Effect And Mechanism Of Cucurmosin Reversing The Paclitaxel Resistance Of Breast Cancer Cells
46. Analysis Of Three Kinds Of LncRNA Related With Paclitaxel Resistance In Ovarian Cancer
47. Mesenchymal Stem Cells Drive Paclitaxel Resistance In ErbB2/ErbB3-Coexpressing Breast Cancer Cells And Its Underlying Mechanisms
48. LINC01118 Regulates Vimentin's Effect On Paclitaxel Sensitivity In Ovarian Cancer Via MiR-134
49. New Factors Regulating The Development And Progression Of NSCLC And Paclitaxel Resistance
50. Mechanism Of Fox M1 Promoting Paclitaxel Resistance By Regulating PHB1
51. Mechanism Of FoxM1 Promoting Paclitaxel Resistance By Regulating PHB1
52. Study Of The Effect And Mechanism Of MiR-650 Targeting DAPK3 On Paclitaxel-Resistance In Ovarian Epithelial Carcinoma
53. Study On The Sensitization Effect Of Esomeprazole To Paclitaxel Chemotherapy In Epithelial Ovarian Cancer Cells
54. The Mechanism Of VMIP-?N-terminal Peptide Reverses Paclitaxel Resistance In Breast Cancer By Regulating MiR-155-3p
55. Effects Of Cisplatin And Paclitaxel Resistance On The Malignant Phenotype Of Esophageal Cancer Cells And Its Mechanism
56. The Study Of Regulatory Effects Of Neddylation On Paclitaxel Resistance And The Related Mechanisms In Ovarian Cancer
57. Expression Profiles Analysis Of Long Non-coding RNA In Paclitaxel-resistant Breast Cancer Cell Lines And Study On The Effect Of LINC00173
58. The Influence And Mechanism Of The Long Non-coding RNA HOTAIR On Paclitaxel Resistance In Ovarian Cancer
59. Reversal Of A549 Resistance By Hedyotis Diffusa Active Compound Combined With Paclitaxel
60. Identification Of Key Genes Responsible For Epirubicin And Paclitaxel Resistance In Breast Cancer Cells
  <<First  <Prev  Next>  Last>>  Jump to